Alzheimer’s Disease and Related Dementias

  • Gregg Warshaw


Cognitive impairment is common in the elderly and often represents an underlying and undetected clinical condition. When accompanied by other medical or social problems, cognitive impairment can precipitate stressful problems for and require decisions from families, caregivers, and clinicians.


Senile Dementia Lewy Body Dementia Progressive Cognitive Impairment Relate Dementia Granulomatous Angiitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Folstein MF, Folstein SE, McHugh PR. “Mini Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98.PubMedCrossRefGoogle Scholar
  2. 2.
    McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group. Neurology 1984;34:939–44.PubMedCrossRefGoogle Scholar
  3. 3.
    NIH Consensus Conference. Differential diagnosis of dementing disease. JAMA 1987;2580:3411–16.Google Scholar
  4. 4.
    Larson EB, Reifler BV, Sami SM, et al. Diagnostic tests in the evaluation of dementia: a prospective study of 200 elderly outpatients. Arch Intern Med 1986;146:1917–22.PubMedCrossRefGoogle Scholar
  5. 5.
    Dekosky ST, Shin WJ, Coupai J, Kirkpatric C. Role of single photon emission computed tomography (SPECT) in the diagnosis of Alzheimer’s disease. Neurology 1987;37:159.Google Scholar
  6. 6.
    Gurland BJ, Cross PS. Epidemiology of psychopathology in old age. Psychiatr Clin North Am 1982;5:11–26.PubMedGoogle Scholar
  7. 7.
    Pfeffer RI, Afifi AA, Chance JM. Prevalence of Alzheimer’s disease in a retirement community. Am J Epidemiol 1987;125:420–36.PubMedGoogle Scholar
  8. 8.
    Roman GC. Senile dementia of the Binswanger type: a vascular form of dementia in the elderly. JAMA 1987;258:1780–8.CrossRefGoogle Scholar
  9. 9.
    Katzman R. Alzheimer’s disease. N Engl J Med 1986;314:964–73.PubMedCrossRefGoogle Scholar
  10. 10.
    Price DL, Whitehouse PJ, Struble RG. Cellular pathology in Alzheimer’s and Parkinson’s diseases. Trends Neurosci 1986;9: 29–33.CrossRefGoogle Scholar
  11. 11.
    Breitner JCS. Clinical genetics and genetic counseling in Alzheimer’s disease. Ann Intern Med 1991;115:601–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Breitner JCS, Silverman JM, Mohs RC, Davis KL. Familial aggregation of Alzheimer’s disease. Neurology 1988;38:207.PubMedCrossRefGoogle Scholar
  13. 13.
    Davies P. Biochemical changes in Alzheimer’s disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer’s type. In: Katzman R, editor. Congenital and acquired cognitive disorders. New York: Raven Press, 1979:153–60.Google Scholar
  14. 14.
    Davis KL, Mohs RC. Cholinergic drugs in Alzheimer’s disease. N Engl J Med 1986;315:1286.PubMedCrossRefGoogle Scholar
  15. 15.
    Cooper JK. Drug treatment of Alzheimer’s disease. Arch Intern Med 1991;151:245–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Lazarus LW, Newton N, Cohler B, et al. Frequency and presentation of depressive symptoms in patients with primary degenerative dementia. Am J Psychiatr 1987;144:41–45.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Gregg Warshaw

There are no affiliations available

Personalised recommendations